Pharsight

Maia Pharms Inc patents expiration

1. Bortezomib patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11679119 MAIA PHARMS INC Bortezomib compositions
Sep, 2042

(18 years from now)

US11752164 MAIA PHARMS INC Bortezomib compositions
Sep, 2042

(18 years from now)

Drugs and Companies using BORTEZOMIB ingredient

Market Authorisation Date: 27 July, 2022

Treatment: Treatment of adult patients with multiple myeloma

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

BORTEZOMIB family patents

Family Patents

2. Sincalide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11110063 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

US11318100 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

US11737983 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

Drugs and Companies using SINCALIDE ingredient

Market Authorisation Date: 22 November, 2022

Treatment: Diagnostic imaging by accelerating the tran it ofa barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the int...

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

SINCALIDE family patents

Family Patents